Clinical Trial Update: RING - Rituximab for Lupus Nephritis With Remission as a Goal [Phase 3]

View source ↗

Summary

This is an update on a Phase 3 trial evaluating rituximab for lupus nephritis with the goal of achieving remission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Frédéric A. Houssiau, MD, PhD | Conditions: Lupus Nephritis | Phase 3 | Status: UNKNOWN